2006
DOI: 10.1089/jir.2006.26.373
|View full text |Cite
|
Sign up to set email alerts
|

IFN-λ: Novel Antiviral Cytokines

Abstract: The first line of defense against viral infections is mediated by interferons (IFN)s, which are produced rapidly by the infected host. Type I IFNs (IFN-alpha/beta) are known to combat viruses both directly by inhibiting viral replication in the cells and indirectly by stimulating the innate and adaptive immune responses. Recently, a novel class of cytokines was discovered and named IFN-lambda (alternatively type III IFN or interleukin-28/29 [IL- 28/29]), based on IFN-like antiviral activity and induction of ty… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
141
1
3

Year Published

2007
2007
2017
2017

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 177 publications
(145 citation statements)
references
References 54 publications
0
141
1
3
Order By: Relevance
“…In addition to their antiviral activity, type I IFNs are key to efficient establishment of the adaptive immune responses (Borden et al, 2007). Type III IFNs (IFN-1, -2 and -3) are new members of the IFN superfamily first discovered in 2003 and shown to be related to type I IFN (Ank et al, 2006). However, they differ by signalling through a receptor complex that is different from that used by type I IFNs.…”
Section: Type 1 Interferon Induction and Signallingmentioning
confidence: 99%
“…In addition to their antiviral activity, type I IFNs are key to efficient establishment of the adaptive immune responses (Borden et al, 2007). Type III IFNs (IFN-1, -2 and -3) are new members of the IFN superfamily first discovered in 2003 and shown to be related to type I IFN (Ank et al, 2006). However, they differ by signalling through a receptor complex that is different from that used by type I IFNs.…”
Section: Type 1 Interferon Induction and Signallingmentioning
confidence: 99%
“…Although IFN-l binds to distinct receptors, IL-28R1 and IL-10Rb (24), it activates signal transduction pathways by a manner similar to that activated by type I IFN (23,24) through inducing tyrosine phosphorylation of STAT proteins (27). IFN-l also shows antiviral abilities, similar to those of type I IFN (28), by inhibiting the replication of a number of viruses, including HCV, hepatitis B virus (HBV), encephalomyocarditis virus, IAV, and vesicular stomatitis virus (23,24,(28)(29)(30)(31).…”
mentioning
confidence: 99%
“…Type I and type III IFNs are produced in response to viral infections (3,4,8,9). Binding of IFNs to their corresponding cellular receptor complexes, despite their differences, induces similar signaling events of the Janus kinase (JAK)-signal transducers and activators of transcription (STAT) signal transduction pathway, including phosphorylation of kinases Jak1 and Tyk2 and activation of latent transcriptional factors STAT1 and STAT2 as well as STAT3, STAT4, and STAT5 to a lesser extent (3,4,6,10).…”
mentioning
confidence: 99%
“…Activated STATs regulate gene expression, and both types of IFNs induce very similar sets of genes, including many genes that encode important mediators of antiviral response (11,12). Consequently, type III and type I IFNs are both able to induce an antiviral state in cells (3,8). However, whereas type I IFN receptors are expressed in most cell types, IFN-R1 demonstrates a more restricted pattern of expression, limiting the response to type III IFNs to primarily epithelium-like tissues (13).…”
mentioning
confidence: 99%